154 related articles for article (PubMed ID: 27729614)
1. Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients.
van den Broek E; Krijgsman O; Sie D; Tijssen M; Mongera S; van de Wiel MA; Belt EJ; den Uil SH; Bril H; Stockmann HB; Ylstra B; Carvalho B; Meijer GA; Fijneman RJ
Oncotarget; 2016 Nov; 7(45):73876-73887. PubMed ID: 27729614
[TBL] [Abstract][Full Text] [Related]
2. Tumour-based Mutational Profiles Predict Visceral Metastasis Outcome and Early Death in Prostate Cancer Patients.
Cussenot O; Timms KM; Perrot E; Blanchet P; Brureau L; Solimeno C; Fromont G; Comperat E; Cancel-Tassin G
Eur Urol Oncol; 2024 Jun; 7(3):597-604. PubMed ID: 38182487
[TBL] [Abstract][Full Text] [Related]
3. Multigene Panel Sequencing Reveals Cancer-Specific and Common Somatic Mutations in Colorectal Cancer Patients: An Egyptian Experience.
Youssef ASE; Abdel-Fattah MA; Lotfy MM; Nassar A; Abouelhoda M; Touny AO; Hassan ZK; Mohey Eldin M; Bahnassy AA; Khaled H; Zekri ARN
Curr Issues Mol Biol; 2022 Mar; 44(3):1332-1352. PubMed ID: 35723313
[TBL] [Abstract][Full Text] [Related]
4. Human colon organoids reveal distinct physiologic and oncogenic Wnt responses.
Michels BE; Mosa MH; Grebbin BM; Yepes D; Darvishi T; Hausmann J; Urlaub H; Zeuzem S; Kvasnicka HM; Oellerich T; Farin HF
J Exp Med; 2019 Mar; 216(3):704-720. PubMed ID: 30792186
[TBL] [Abstract][Full Text] [Related]
5. The frequency of NRAS mutation in stool samples of Iranian colorectal cancers compared to Finnish patients.
Saberi F; Youssef O; Kokkola A; Khodadoostan M; Puolakkainen P; Salehi R; Knuutila S
J Res Med Sci; 2024; 29():4. PubMed ID: 38524743
[TBL] [Abstract][Full Text] [Related]
6. Driver genes exome sequencing reveals distinct variants in African Americans with colorectal neoplasia.
Ashktorab H; Azimi H; Varma S; Lee EL; Laiyemo AO; Nickerson ML; Brim H
Oncotarget; 2019 Apr; 10(27):2607-2624. PubMed ID: 31080553
[TBL] [Abstract][Full Text] [Related]
7. Single Cell Genetic Profiling of Tumors of Breast Cancer Patients Aged 50 Years and Older Reveals Enormous Intratumor Heterogeneity Independent of Individual Prognosis.
Liegmann AS; Heselmeyer-Haddad K; Lischka A; Hirsch D; Chen WD; Torres I; Gemoll T; Rody A; Thorns C; Gertz EM; Alkemade H; Hu Y; Habermann JK; Ried T
Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34282768
[TBL] [Abstract][Full Text] [Related]
8. Distinct Driver Pathway Enrichments and a High Prevalence of
Tapia-Valladares C; Valenzuela G; González E; Maureira I; Toro J; Freire M; Sepúlveda-Hermosilla G; Ampuero D; Blanco A; Gallegos I; Morales F; Erices JI; Barajas O; Ahumada M; Contreras HR; González J; Armisén R; Marcelain K
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731914
[TBL] [Abstract][Full Text] [Related]
9. Systematic identification of mutations and copy number alterations associated with cancer patient prognosis.
Smith JC; Sheltzer JM
Elife; 2018 Dec; 7():. PubMed ID: 30526857
[TBL] [Abstract][Full Text] [Related]
10. Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases.
Aparicio T; Henriques J; Svrcek M; Zaanan A; Manfredi S; Casadei-Gardini A; Tougeron D; Gornet JM; Jary M; Terrebonne E; Piessen G; Afchain P; Lecaille C; Pocard M; Lecomte T; Rimini M; Di Fiore F; Le Brun Ly V; Cascinu S; Vernerey D; Laurent Puig P
Br J Cancer; 2024 May; ():. PubMed ID: 38745088
[TBL] [Abstract][Full Text] [Related]
11. Genomic profiles of Indonesian colorectal cancer patients.
Abdullah M; Meilany S; Trimarsanto H; Malik SG; Sukartini N; Idrus F; Nursyirwan SA; Muzellina VN; Pribadi RR; Utari AP; Maulahela H; Syam AF
F1000Res; 2022; 11():443. PubMed ID: 37125020
[No Abstract] [Full Text] [Related]
12. Whole Genome Sequencing Analysis of a Stage IV Colon Cancer Patient with a 10-Year Disease-Free Survival following Systemic Chemotherapy/Bevacizumab.
Yeatman TJ; Yang M; Coppola D
Case Rep Gastroenterol; 2018; 12(3):729-736. PubMed ID: 30631260
[TBL] [Abstract][Full Text] [Related]
13. Identification of different mutational profiles in cancers arising in specific colon segments by next generation sequencing.
Oliveira DM; Laudanna C; Migliozzi S; Zoppoli P; Santamaria G; Grillone K; Elia L; Mignogna C; Biamonte F; Sacco R; Corcione F; Viglietto G; Malanga D; Rizzuto A
Oncotarget; 2018 May; 9(35):23960-23974. PubMed ID: 29844865
[TBL] [Abstract][Full Text] [Related]
14. Identification of copy number alterations in colon cancer from analysis of amplicon-based next generation sequencing data.
Oliveira DM; Santamaria G; Laudanna C; Migliozzi S; Zoppoli P; Quist M; Grasso C; Mignogna C; Elia L; Faniello MC; Marinaro C; Sacco R; Corcione F; Viglietto G; Malanga D; Rizzuto A
Oncotarget; 2018 Apr; 9(29):20409-20425. PubMed ID: 29755661
[TBL] [Abstract][Full Text] [Related]
15. Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma.
Boyle EM; Blaney P; Stoeckle JH; Wang Y; Ghamlouch H; Gagler D; Braunstein M; Williams L; Tenenbaum A; Siegel A; Chen X; Varma G; Avigan J; Li A; Jinsi M; Kaminetzsky D; Arbini A; Montes L; Corre J; Rustad EH; Landgren O; Maura F; Walker BA; Bauer M; Bruno B; Tsirigos A; Davies FE; Morgan GJ
Clin Cancer Res; 2023 Oct; 29(19):3901-3913. PubMed ID: 37449980
[TBL] [Abstract][Full Text] [Related]
16. Interchromosomal Translocations as a Means to Map Chromosome Territories in Breast Cancer.
Parl FF; Dupont WD; Crooke PS
Cancer Inform; 2019; 18():1176935119842573. PubMed ID: 31019364
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of simulation methods for tumor subclonal reconstruction.
Lai J; Liu Y; Scharpf RB; Karchin R
ArXiv; 2024 Feb; ():. PubMed ID: 38410652
[TBL] [Abstract][Full Text] [Related]
18. KRAS, NRAS, BRAF, HER2 and microsatellite instability in metastatic colorectal cancer - practical implications for the clinician.
Afrăsânie VA; Marinca MV; Alexa-Stratulat T; Gafton B; Păduraru M; Adavidoaiei AM; Miron L; Rusu C
Radiol Oncol; 2019 Sep; 53(3):265-274. PubMed ID: 31553708
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of KRAS and BRAF in stage I-III colorectal cancer. A systematic review.
Gallo G; Sena G; Vescio G; Papandrea M; Sacco R; Trompetto M; Sammarco G
Ann Ital Chir; 2019; 90():127-137. PubMed ID: 30739887
[TBL] [Abstract][Full Text] [Related]
20. ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer.
Pietrantonio F; Di Nicolantonio F; Schrock AB; Lee J; Tejpar S; Sartore-Bianchi A; Hechtman JF; Christiansen J; Novara L; Tebbutt N; Fucà G; Antoniotti C; Kim ST; Murphy D; Berenato R; Morano F; Sun J; Min B; Stephens PJ; Chen M; Lazzari L; Miller VA; Shoemaker R; Amatu A; Milione M; Ross JS; Siena S; Bardelli A; Ali SM; Falcone A; de Braud F; Cremolini C
J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29370427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
